文献速递脑血管病外科

支架孔隙率、血小板功能检测使用及双联抗血小板治疗时长对颅内动脉瘤支架置入术后临床与影像学结局的影响:一项Meta分析

Effect of Stent Porosity, Platelet Function Test Usage, and Dual Antiplatelet Therapy Duration on Clinical and Radiographic Outcomes After Stenting for Cerebral Aneurysms: A Meta-Analysis.
PubMed 文献 · World Neurosurg · 2022-12-16

该Meta分析检索PubMed至2021年3月29日,纳入105项研究(89项回顾性、16项前瞻性)共117个支架置入队列,按支架孔隙率、血小板功能检测(PFT)使用及双联抗血小板治疗(DAPT)时长分层。结果显示中等孔隙率支架出血事件发生率低于低孔隙率支架(π=0.32% vs 1.36%,P=0.01),动脉瘤闭塞率优于高孔隙率(π=6.18% vs 14.42%,P=0.001)和低孔隙率支架(π=6.18% vs 11.71%,P=0.04);使用PFT者不良临床结局较少(π=3.54% vs 5.94%,P=0.04);DAPT时长对结局无影响。

要点

  • 中等孔隙率支架出血事件发生率低于低孔隙率支架(π=0.32% vs 1.36%,P=0.01)。
  • 中等孔隙率支架动脉瘤闭塞率优于高孔隙率(π=6.18% vs 14.42%,P=0.001)和低孔隙率支架(π=6.18% vs 11.71%,P=0.04)。
  • 使用PFT者不良临床结局少于未使用者(π=3.54% vs 5.94%,P=0.04),DAPT时长对结局无影响。

核心结论

  • 在本Meta分析中,中等孔隙率支架和使用PFT与结局显著改善相关,未检测到DAPT时长对结局的影响。

研究设计与样本

  • 检索PubMed(2021年3月29日)纳入报告支架类型和DAPT时长的颅内动脉瘤支架置入研究,共105项研究(89项回顾性、16项前瞻性)和117个支架置入队列(高孔隙率50个、中等孔隙率17个、低孔隙率50个),采用随机效应Meta分析。

主要发现

  • 高、中、低孔隙率队列的PFT使用率分别为26.0%、47.1%、62.0%,平均DAPT时长分别为3.51±2.33、3.97±1.92、5.18±2.27个月。
  • 中等孔隙率支架出血事件发生率低于低孔隙率支架(π=0.32% vs 1.36%,P=0.01)。
  • 中等孔隙率支架动脉瘤闭塞率优于高孔隙率(π=6.18% vs 14.42%,P=0.001)和低孔隙率支架(π=6.18% vs 11.71%,P=0.04)。
  • 支架内狭窄发生率中等孔隙率(π=0.57%)和高孔隙率(π=1.51%)均低于低孔隙率支架(π=3.30%,P<0.05)。
  • 使用PFT者不良临床结局少于未使用者(π=3.54% vs 5.94%,P=0.04),DAPT时长对结局无影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of stents with various porosities for treating cerebral aneurysms requires dual antiplatelet therapy (DAPT) without clear guidelines on the utility of platelet function tests (PFTs) and the duration of DAPT. We sought to determine the effects of stent porosity, PFT usage, and DAPT duration on the radiographic and clinical outcomes after stenting of cerebral aneurysms. METHODS: PubMed was searched on March 29, 2021 for studies of cerebral aneurysm stenting that had specified the stent type and DAPT duration. A random effects meta-analysis was used to measure the prevalence of nonprocedural thrombotic and hemorrhagic events, clinical outcomes, aneurysm occlusion, and in-stent stenosis stratified by stent porosity, PFT usage, and DAPT duration. RESULTS: The review yielded 105 studies (89 retrospective and 16 prospective) with 117 stenting cohorts (50 high porosity, 17 intermediate porosity, and 50 low porosity). In the high-, intermediate-, and low-porosity stenting cohorts, PFT usage was 26.0%, 47.1%, and 62.0% and the mean DAPT duration was 3.51 ± 2.33, 3.97 ± 1.92, and 5.18 ± 2.27 months, respectively. The intermediate-porosity stents showed a reduced incidence of hemorrhagic events (π = 0.32%) compared with low-porosity stents (π = 1.36%; P = 0.01) and improved aneurysm occlusion (π = 6.18%) compared with high-porosity stents (π = 14.42%; P = 0.001) and low-porosity stents (π = 11.71%; P = 0.04). The prevalence of in-stent stenosis was lower for the intermediate-porosity (π = 0.57%) and high-porosity (π = 1.51%) stents than for the low-porosity stents (π = 3.30%; P < 0.05). PFT use had resulted in fewer poor clinical outcomes (π = 3.54%) compared with those without PFT use (π = 5.94%; P = 0.04). The DAPT duration had no effect on the outcomes. CONCLUSIONS: In the present meta-analysis, which had selected for studies of cerebral aneurysm stenting that had reported the DAPT duration, intermediate-porosity stents and PFT use had resulted significantly improved outcomes. No effect of DAPT duration could be detected.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gonzalez SM, Iordanou J, Adams W, et al. Effect of Stent Porosity, Platelet Function Test Usage, and Dual Antiplatelet Therapy Duration on Clinical and Radiographic Outcomes After Stenting for Cerebral Aneurysms: A Meta-Analysis. World Neurosurg. 2022. PMID: 36529432. doi:10.1016/j.wneu.2022.12.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。